Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets
- PMID: 31806884
- DOI: 10.1038/s41568-019-0226-5
Altered cellular metabolism in gliomas - an emerging landscape of actionable co-dependency targets
Abstract
Altered cellular metabolism is a hallmark of gliomas. Propelled by a set of recent technological advances, new insights into the molecular mechanisms underlying glioma metabolism are rapidly emerging. In this Review, we focus on the dynamic nature of glioma metabolism and how it is shaped by the interaction between tumour genotype and brain microenvironment. Recent advances integrating metabolomics with genomics are discussed, yielding new insight into the mechanisms that drive glioma pathogenesis. Studies that shed light on interactions between the tumour microenvironment and tumour genotype are highlighted, providing important clues as to how gliomas respond to and adapt to their changing tissue and biochemical contexts. Finally, a road map for the discovery of potential new glioma drug targets is suggested, with the goal of translating these new insights about glioma metabolism into clinical benefits for patients.
Similar articles
-
Cancer metabolism as a central driving force of glioma pathogenesis.Brain Tumor Pathol. 2016 Jul;33(3):161-8. doi: 10.1007/s10014-016-0265-5. Epub 2016 Jun 13. Brain Tumor Pathol. 2016. PMID: 27295313 Free PMC article. Review.
-
Tumour immune landscape of paediatric high-grade gliomas.Brain. 2021 Oct 22;144(9):2594-2609. doi: 10.1093/brain/awab155. Brain. 2021. PMID: 33856022 Free PMC article. Review.
-
[Biomarkers of glioma: recent advance and potential applications].Zhonghua Bing Li Xue Za Zhi. 2009 Mar;38(3):145-7. Zhonghua Bing Li Xue Za Zhi. 2009. PMID: 19575846 Chinese. No abstract available.
-
The Role of Molecular Diagnostics in the Management of Patients with Gliomas.Curr Treat Options Oncol. 2016 Oct;17(10):51. doi: 10.1007/s11864-016-0430-4. Curr Treat Options Oncol. 2016. PMID: 27501915 Review.
-
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper.Allergy. 2024 Jun;79(6):1419-1439. doi: 10.1111/all.15994. Epub 2024 Jan 24. Allergy. 2024. PMID: 38263898 Review.
Cited by
-
Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas.Front Mol Neurosci. 2022 Nov 4;15:1037835. doi: 10.3389/fnmol.2022.1037835. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36407768 Free PMC article.
-
PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients.Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):186-202. doi: 10.21873/cgp.20440. Cancer Genomics Proteomics. 2024. PMID: 38423596 Free PMC article.
-
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma.BMC Cancer. 2024 Jan 5;24(1):37. doi: 10.1186/s12885-023-11772-8. BMC Cancer. 2024. PMID: 38183008 Free PMC article.
-
A Novel Risk Score Model Based on Eleven Extracellular Matrix-Related Genes for Predicting Overall Survival of Glioma Patients.J Oncol. 2022 Apr 29;2022:4966820. doi: 10.1155/2022/4966820. eCollection 2022. J Oncol. 2022. PMID: 35528238 Free PMC article.
-
Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas.Brain Sci. 2021 Dec 18;11(12):1655. doi: 10.3390/brainsci11121655. Brain Sci. 2021. PMID: 34942957 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical